FDA Advisers Support Use of Pfizer Vaccine in US Amid Concerns of Side Effects

Wesley Wheeler holds up a sample of the vial that will be used to transport the Pfizer Covid-19 vaccine during a hearing in Washington on Dec. 10, 2020. Samuel Corum/POOL/AFP via Getty Images

WASHINGTON—A 23-member vaccine advisory panel voted on Dec. 10 to support the emergency use authorization (EUA) of the COVID-19 vaccine created by Pfizer-BioNTech.

The final decision and official authorization will likely be taken up quickly by the Food and Drug Administration (FDA), ultimately triggering a massive distribution effort.